Advanced Wound Care Technology From AcryMed Now Used To Reduce Nosocomial Infections
New SilvaSorb Site Dressing Offers Improved Infection Control Around Catheters and Other Percutaneous Devices.
PORTLAND, Oregon (PRWEB) July 5, 2005 – AcryMed, experts specializing in
infection control and wound care technology today announced the availability of
an advanced medical device that provides increased protection against infection
around catheters, central venous (CV) lines, and other indwelling percutaneous
devices. By combining its patented MicroLattice and silver antimicrobial
technologies with an advanced design, AcryMed has developed SilvaSorb Site, an
antimicrobial skirt for devices that penetrate the skin. This new product offers
several advantages over other site protection devices including superior
infection-fighting protection and a pediatric-safe formula.
According to
the Centers for Disease Control and Prevention, hospital and healthcare-related
infections affect more than two million patients each year – 250,000 of which
are related to infections around catheters, intravenous lines and other
insertion sites. Average treatment costs exceed $57,000 per patient
incident.
SilvaSorb Site’s advanced design allows it to wrap snuggly
around catheters, CV lines, tubes and other medical devices inserted through the
skin. While other site dressings may leave gaps that serve as entry areas for
infection, SilvaSorb Site dressing eliminates this vulnerability (figure 1-3).
In addition, the dressing’s thin, flexible construction allows it to lie flat
against the skin providing a more secure, more comfortable protection.
SilvaSorb Site dressing also incorporates AcryMed’s patented
MicroLattice technology, which absorbs excess fluid and ensures the optimal
moisture level around the insertion site. The company’s SilvaSorb technology
uniquely provides a sustained release of a highly effective ionic silver
antimicrobial, so the site protection device continues to kill infection-causing
germs for up to seven days. Studies show that SilvaSorb Site reduces bacteria
counts greater than 99.99%.
Pediatric Safe
Some site dressings
contain potentially harsh antimicrobial chlorhexidine gluconate (CHG), which may
cause irritation and other hypersensitivity reactions to the skin. For this
reason, these products warn against use in pediatric applications and potential
danger in use on children less than sixteen years of age. However, the ionic
silver used in SilvaSorb Site is both non-toxic and non-irritating. It is safe
to apply directly over insertion sites and wound areas.
SilvaSorb Site is
currently available in two sizes: a 1” dressing to go around small diameter
devices up to 4 mm in diameter, and a 1.75” design to accommodate 5-13 mm
devices such as gastric feeding tubes.
SilvaSorb Site is currently being
distributed in the U.S. exclusively by Medline Industries. Medline is the
nation’s largest privately held manufacturer and distributor of health care
supplies. The company manufactures and distributes more than 100,000 products to
hospitals, extended care facilities, surgery centers, home care dealers and
agencies and other markets. Medline can be contacted at www.medline.com or (800)
633-5463.
About AcryMed:
Since 1993, AcryMed has been at the
forefront of breakthroughs in the areas of wound care and infection prevention.
The company’s technologies and products are currently licensed by distribution
partners and used today in hospitals, doctors’ offices, and clinics around the
world. For more information on AcryMed, visit their website at www.acrymed.com or call (503)
624-9830.
# # #
Source : http://www.prweb.com/releases/2005/7/prweb256731.htm